Frequency of Smoking and Smokeless Tobacco and Its Impact on In Hospital Outcomes of Patient Less Than 45 Years of Age with ACS
DOI:
https://doi.org/10.70749/ijbr.v3i2.661Keywords:
Acute Coronary Syndrome, Cardiovascular Disease, Myocardial Infarction, Smoking, TobbacoAbstract
Objective: This study has been designed to determine frequency of smoking and smokeless tobacco and its impact on in-hospital MACE among acute coronary syndrome patients of age less than 45 years managed at public sector hospital in Karachi, Pakistan. Methodology: This cross-sectional study was performed in Department of Cardiology, National Institute of Cardiovascular Diseases, Karachi from 1st January 2024 to 30th July 2024. Patients of both the gender of age at least 18-45 years and presenting with ACS were studied. Patients were followed till their discharge or in-hospital mortality to record final outcome. Results: Total 172 patients were studied with mean age of 40.5 ± 4.8 years. Majority of participants were males (89%). Most of the patients were smokers (39.5%) while some were consuming smokeless tobacco (12.2%) and few were using both (3.5%). Smoking was higher in males (100% versus 0%) whereas smokeless tobacco consumption was higher in females (38.1% versus 61.9%). Among smokers, STEMI (60.3%) was more prevalent followed by nSTEMI (23.5%) and unstable angina (16.2%). In smokeless tobacco users, unstable angina (61.9%) was more common followed by nSTEMI (28.6%) and STEMI (9.5%). Multiple level disease was more common in smokers (66.2%) while among smokeless tobacco users single level was common (66.7%). Education and comorbidity was significantly different. Conclusion: The present study found that STEMI and multi-level vessel disease was common in smokers whereas in consumers of smokeless tobacco, unstable angina and single-level disease was frequent. No differences were found in terms of mortality among smokers, consumers of smokeless tobacco and those who were not smoking.
Downloads
References
World Health Organization. (2011). WHO report on the global tobacco epidemic, 2011: Warning about the dangers of tobacco: Executive summary (No. WHO/NMH/TFI/11.3). World health organization. https://iris.who.int/bitstream/handle/10665/70680/WHO_NMH_TFI_11.3_rus.pdf
NCI. (2014). National Cancer Institute and Centers for Disease Control and Prevention. Smokeless Tobacco and Public Health: A Global Perspective.
Reitsma, M. B., Fullman, N., Ng, M., Salama, J. S., Abajobir, A., Abate, K. H., ... & Patton, G. C. (2017). Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. The Lancet, 389(10082), 1885-1906. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)30819-X/fulltext
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209-249. https://doi.org/10.3322/caac.21660
Sinha, D., Agarwal, N., & Gupta, P. (2015). Prevalence of smokeless tobacco use and number of users in 121 countries. British Journal of Medicine and Medical Research, 9(6), 1-20. https://doi.org/10.9734/bjmmr/2015/16285
Campbell, L. R., Brown, B. G., Jones, B. A., Marano, K. M., & Borgerding, M. F. (2015). Study of cardiovascular disease biomarkers among tobacco consumers, Part 1: Biomarkers of exposure. Inhalation Toxicology, 27(3), 149-156. https://doi.org/10.3109/08958378.2015.1013228
Cheng, Y., Reyes-Guzman, C. M., Christensen, C. H., Rostron, B. L., Edwards, K. C., Wang, L., Feng, J., Jarrett, J. M., Ward, C. D., Xia, B., Kimmel, H. L., Conway, K., Leggett, C., Taylor, K., Lawrence, C., Niaura, R., Travers, M. J., Hyland, A., Hecht, S. S., … Van Bemmel, D. M. (2020). Biomarkers of exposure among adult smokeless tobacco users in the population assessment of tobacco and health study (Wave 1, 2013–2014). Cancer Epidemiology, Biomarkers & Prevention, 29(3), 659-667. https://doi.org/10.1158/1055-9965.epi-19-0766
Cornelius, M. E., Loretan, C. G., Wang, T. W., Jamal, A., & Homa, D. M. (2022). Tobacco product use among adults — United States, 2020. MMWR. Morbidity and Mortality Weekly Report, 71(11), 397-405. https://doi.org/10.15585/mmwr.mm7111a1
Piano, M. R., Benowitz, N. L., FitzGerald, G. A., Corbridge, S., Heath, J., Hahn, E., Pechacek, T. F., & Howard, G. (2010). Impact of smokeless tobacco products on cardiovascular disease: Implications for policy, prevention, and treatment. Circulation, 122(15), 1520-1544. https://doi.org/10.1161/cir.0b013e3181f432c3
Henley, S. J., Thun, M. J., Connell, C., & Calle, E. E. (2005). Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes & Control, 16(4), 347-358. https://doi.org/10.1007/s10552-004-5519-6
Boffetta, P., & Straif, K. (2009). Use of smokeless tobacco and risk of myocardial infarction and stroke: Systematic review with meta-analysis. BMJ, 339(aug18 2), b3060-b3060. https://doi.org/10.1136/bmj.b3060
Frobert, O., Reitan, C., Hatsukami, D. K., Pernow, J., Omerovic, E., & Andell, P. (2019). Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk for cardiac events. Open Heart, 6(2), e001109. https://doi.org/10.1136/openhrt-2019-001109
Reference US Food and Drug Administration. Family Smoking Prevention And Tobacco Control And Federal Retirement Reform. Public Law 111–31—June 22, 2009. https://www.govinfo.gov/content/pkg/PLAW-111publ31/pdf/PLAW-111publ31.pdf
Henley, S. J., Connell, C. J., Richter, P., Husten, C., Pechacek, T., Calle, E. E., & Thun, M. J. (2007). Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco. Tobacco Control, 16(1), 22-28. https://doi.org/10.1136/tc.2006.018069
Pericot-Valverde, I., Elliott, R. J., Priest, J. S., Barret, T., Yoon, J. H., Miller, C. C., Okoli, C. T., Haliwa, I., Ades, P. A., & Gaalema, D. E. (2019). Patterns of tobacco use among smokers prior to hospitalization for an acute cardiac event: Use of combusted and non-combusted products. Preventive Medicine, 128, 105757. https://doi.org/10.1016/j.ypmed.2019.105757
Gallucci, G., Tartarone, A., Lerose, R., Lalinga, A. V., & Capobianco, A. M. (2020). Cardiovascular risk of smoking and benefits of smoking cessation. Journal of Thoracic Disease, 12(7), 3866-3876. https://doi.org/10.21037/jtd.2020.02.47
Bhaumik, S. S., Placek, C., Kochumoni, R., Lekha, T. R., Prabhakaran, D., Hitsman, B., Huffman, M. D., Harikrishnan, S., & Goenka, S. (2018). Tobacco cessation among acute coronary syndrome patients in Kerala, India: Patient and provider perspectives. Qualitative Health Research, 29(8), 1145-1160. https://doi.org/10.1177/1049732318817047
Modi, H. P., Chaudhari, R., Chaudhari, K., & Patel, P. B. (2024). A Comparative Analysis Clinicoangiographic Patterns of Coronary Artery Disease in Smokers and Smokeless Tobacco Users. Res. J. Med. Sci, 18, 183-186. https://demo.makhillpublications.co/files/published-files/mak-rjms/2024/483-486.pdf
Budania, S. K. (2023). To compare the clinical and angiographic patterns of coronary artery disease in smokers and users of smokeless tobacco. International Journal of Life Sciences Biotechnology and Pharma Research. 12(2), 201-205. https://www.ijlbpr.com/uploadfiles/34vol12issue2pp201-205.20230401122749.pdf
Iqbal, N., Irfan, M., Ashraf, N., Awan, S., & Khan, J. A. (2015). Prevalence of tobacco use among women: A cross sectional survey from a squatter settlement of Karachi, Pakistan. BMC Research Notes, 8(1). https://doi.org/10.1186/s13104-015-1455-7
Sharma, R., Kanaan, M., & Siddiqi, K. (2024). The diversity in tobacco use among women of reproductive age (15–49 years) in Pakistan: A secondary analysis of a multiple indicator cluster survey 2016–2018. Nicotine and Tobacco Research, 26(7), 931-939. https://doi.org/10.1093/ntr/ntae016
Rakowski, T., Siudak, Z., Dziewierz, A., Dubiel, J. S., & Dudek, D. (2012). Impact of smoking status on outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Journal of Thrombosis and Thrombolysis, 34(3), 397-403. https://doi.org/10.1007/s11239-012-0764-0
Aune, E., Røislien, J., Mathisen, M., Thelle, D. S., & Otterstad, J. E. (2011). The "smoker's paradox" in patients with acute coronary syndrome: A systematic review. BMC Medicine, 9(1). https://doi.org/10.1186/1741-7015-9-97
Toluey, M., Ghaffari, S., Tajlil, A., Nasiri, B., & Rostami, A. (2019). The impact of cigarette smoking on infarct location and in-hospital outcome following acute ST-elevation myocardial infarction. Journal of Cardiovascular and Thoracic Research, 11(3), 209-215. https://doi.org/10.15171/jcvtr.2019.35
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
